CoLabs Int'l
Huntington Beach, US · Nevada corporation
Founders & leadership
LC
Laura CohenNamed on SEC filing
LL
Lisa LeBlancNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$6.4M disclosed across 5 rounds · 2013–2023
▶$315KraisedJun 2023 · 4 investors · Other Health Care
▶$315KraisedJun 2023 · 4 investors · Other Health Care
Officers, directors & promoters on the filing
- Peter Barton HuttDirector
- Dean StathakisDirector
- Charles FrittsDirector
- Laura CohenExecutive Officer, Director, Promoter
- Lisa LeBlancExecutive Officer, Director, Promoter
- William CohenExecutive Officer, Promoter
- Daniel TraynorExecutive Officer
- Offering amount
- $600K
- Amount sold
- $315K
- Minimum investment
- $15K
- First sale
- Feb 2023
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 04
▶$165KraisedSep 2021 · 2 investors · Other Health CareRule 506(c)
▶$165KraisedSep 2021 · 2 investors · Other Health Care
Rule 506(c)Officers, directors & promoters on the filing
- Daniel TratynorExecutive Officer
- Dean StathakisDirector
- Peter Barton-HuttDirector
- Charles FrittsDirector
- Gerald BirchExecutive Officer
- Laura CohenExecutive Officer, Director, Promoter
- William CohenPromoter
- Lisa LeBlancExecutive Officer, Director, Promoter
- Offering amount
- $16.5M
- Amount sold
- $165K
- Minimum investment
- $50K
- First sale
- Aug 2021
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06c
▶$540KraisedFeb 2021 · 3 investors · PharmaceuticalsRule 506(b)
▶$540KraisedFeb 2021 · 3 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Dean StathakisDirector
- Gerald BirchExecutive Officer
- Charles FrittsDirector
- Laura CohenExecutive Officer, Director, Promoter
- Lisa LeBlancExecutive Officer, Director, Promoter
- Peter Barton-HuttDirector
- Offering amount
- $540K
- Amount sold
- $540K
- Minimum investment
- $50K
- First sale
- Feb 2018
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06b
▶$3MraisedFeb 2021 · 10 investors · PharmaceuticalsRule 506(b)
▶$3MraisedFeb 2021 · 10 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Laura CohenExecutive Officer, Director, Promoter
- Gerald BirchExecutive Officer
- Charles FrittsDirector
- Dean StathakisDirector
- Peter Barton-HuttDirector
- Lisa LeBlancExecutive Officer, Director, Promoter
- Offering amount
- $3M
- Amount sold
- $3M
- Minimum investment
- $20K
- First sale
- Jun 2013
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06b
▶$2.4MraisedJan 2021 · 26 investors · PharmaceuticalsRule 506(b)
▶$2.4MraisedJan 2021 · 26 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Laura CohenExecutive Officer, Director, Promoter
- Lisa LeBlancExecutive Officer, Director, Promoter
- Offering amount
- $2.4M
- Amount sold
- $2.4M
- Minimum investment
- $3K
- First sale
- Jan 2019
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has CoLabs Int'l raised?
- CoLabs Int'l has disclosed $6.4M raised across 5 rounds.
- Where is CoLabs Int'l headquartered?
- CoLabs Int'l is headquartered in Huntington Beach, US.